Akèy › Sendwòm myelodisplastik › Minnesota › Duluth
Etid klinik pou Sendwòm myelodisplastik nan Duluth, MN
3 etid pou Sendwòm myelodisplastik ap chèche patisipan nan sit nan ak bò kote Duluth (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Essentia Health Cancer Center, Duluth
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Ap rekriteFaz 2
- Essentia Health Cancer Center, Duluth
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Duluth
Etid Sendwòm myelodisplastik nan lòt vil
- Houston, TX43 etid
- Baldwin Park, CA26 etid
- New York City, NY21 etid
- Seattle, WA21 etid
- Washington, DC20 etid
- Boston, MA19 etid
- Tampa, FL19 etid
- Miami, FL17 etid
- Columbus, OH14 etid
- Durham, NC14 etid
- Chicago, IL13 etid
- Atlanta, GA13 etid
Lòt etid nan Duluth
- Kansè Poumon ki pa ti selil13 etid
- Kansè poumon11 etid
- Kansè pwostat7 etid
- Kansè nan tete7 etid
- Kansè kolon6 etid
- Kansè vejik6 etid
- Leksemi mieloïd egi6 etid
- Kansè Endomèt5 etid
- Kansè lestomak5 etid
- Kansè rektal5 etid
- Kansè Ezofajyen5 etid
- Kansè larinks5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.